|
| sec_combustion =
}}
'''Ribavirin''' je [[organsko jedinjenje]], koje sadrži 8 [[atom]]a [[ugljenik]]a i ima [[Molekulska masa|molekulsku masu]] od 244,205 [[ЈединицаJedinica атомскеatomske масеmase|Da]].<ref>Sidwell RW, Bailey KW, Wong MH, Barnard DL, Smee DF: In vitro and in vivo influenza virus-inhibitory effects of viramidine. Antiviral Res. 2005 Oct;68(1):10-7. [[PubMed|PMID]] [http://www.ncbi.nlm.nih.gov/pubmed/16087250 16087250]</ref><ref>Sidwell RW, Huffman JH, Khare GP, Allen LB, Witkowski JT, Robins RK: Broad-spectrum antiviral activity of Virazole: 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide. Science. 1972 Aug 25;177(50): 705-6. [[PubMed|PMID]] [http://www.ncbi.nlm.nih.gov/pubmed/4340949 4340949]</ref><ref>Alvarez D, Dieterich DT, Brau N, Moorehead L, Ball L, Sulkowski MS: Zidovudine use but not weight-based ribavirin dosing impacts anaemia during HCV treatment in HIV-infected persons. J Viral Hepat. 2006 Oct;13(10):683-9. [[PubMed|PMID]] [http://www.ncbi.nlm.nih.gov/pubmed/16970600 16970600]</ref><ref>Bani-Sadr F, Carrat F, Pol S, Hor R, Rosenthal E, Goujard C, Morand P, Lunel-Fabiani F, Salmon-Ceron D, Piroth L, Pialoux G, Bentata M, Cacoub P, Perronne C: Risk factors for symptomatic mitochondrial toxicity in HIV/hepatitis C virus-coinfected patients during interferon plus ribavirin-based therapy. J Acquir Immune Defic Syndr. 2005 Sep 1;40(1):47-52. [[PubMed|PMID]] [http://www.ncbi.nlm.nih.gov/pubmed/16123681 16123681]</ref><ref>{{Cite pmid|21059682|noedit}}</ref><ref>{{cite pmid|18048412|noedit}}</ref>
== Osobine ==
|
